across the world

Our technologies are
acknowledged by various
national & international journals

Troikaa’s innovative products are backed by clinical trials conducted at various prestigious Medical Colleges and Institutes. The results of these clinical trials are then published in various national and international journals.


An open label single arm single centre clinical study to evaluate the safety and efficacy of Troypofol (Propofol 1% (10 mg/ml) injection) in induction of general anesthesia.

Dynapar Tablet

Combination of diclofenac with paracetamol offer better pain relief than ibuprofen alone in impacted third molar extraction: a randomized controlled trial

Xykaa Extend

Bioequivalence and pharmacokinetic evaluation of two formulations of paracetamol ER 650 mg: a single dose randomized two period crossover comparison in healthy indian adult volunteers
Dual release paracetamol in osteoarthritis of knee: a randomized controlled clinical trial

Dynapar QPS

Evaluation of skin penetration of diclofenac from a novel topical non aqueous solution: a comparative bioavailability study
A novel quick penetrating solution of diclofenac (topical) for management of acute musculoskeletal pain
A comparative dermal microdialysis study of diclofenac QPS versus conventional 1% diclofenac gel
Penetration of diclofenac from novel quick penetrating solution. A comparative scintigraphy study with gel
Prospective, open‑Label, randomized, parallel group, comparative clinical study of two topical formulations of diclofenac diethylamine in the treatment of acute painful musculoskeletal condition” is as follows:

Dynapar AQ 75 mg / 1ml

Clinical efficacy of a novel new injectable diclofenac formulation designed for intradeltoid use in post-operative pain management
Pharmacokinetic profile of a new formulation of injection diclofenac designed for intradeltoid use
Evaluation of the effectiveness and safety of a new formulation of Injection Diclofenac Dynapar AQ (75 mg/ml) in the management of post operative pain: A pilot study
Physical incompatibility of injection diclofenac sodium with isolyte P
Pharmacokinetic profile of an intradeltoid diclofenac injection in obese Indian volunteers
Comparative bioavailability study of a new formulation of injection of 75 mg diclofenac sodium in 1 ml with the conventional injection of 75 mg diclofenac sodium given in 3 ml volume
Diclofenac 75 mg/1ml intradeltoid injection for post operative pain management in patients with BMI > 25 kg/m2
Dynapar AQ IV Bolus injection for postoperative pain

Phlebotroy QPS

A prospective randomized study to evaluate safety and efficacy of heparin topical solution (1000 IU/ml) compared to heparin topical gel (200 IU/g) in prevention of infusion-associated phlebitis
Topical heparin for infusion associated superficial thrombophlebitis: A preventive approach
An open-label, single-arm, single-center, clinical study to evaluate safety and efficacy of heparin sodium topical solution (1,000 IU/mL) in prevention of infusion-associated superficial thrombophlebitis
Role of topical application of heparin in prophylaxis of superficial thrombophlebitis associated with peripheral venous cannulation
Efficacy of topical heparin in preventing the incidence of thrombophlebitis after peripheral intra venous cannulation
To evaluate the efficacy of heparin sodium topical solution in prevention of intravenous cannula related thrompbophlebitis
Novel topical quick penetrating solution of heparin in management of superficial thrombophlebitis: results of randomized active controlled trial
Prevention of superficial thrombophlebitis in patients coming for surgery: Comparison of topical quick penetrating solution(QPS) of heparin versus heparin gel.
A study to evaluate the efficacy of topical quick penetrating solution of heparin in preventing thrombophlebitis.
Evaluation of safety and efficacy of quick penetrating heparin solution (1000 IU/ml) in prevention of intravenous cannula related thrombophlebitis: A prospective, randomized, comparative, parallel group clinical study.
Efficacy of topical heparin in prevention of superficial thrombophlebitis before peripheral venous cannulation.